As states authorize and implement Prescription Drug Affordability Boards, health care stakeholders have raised concerns about both their decision-making processes and the potential negative consequences of those decisions. PDABs are inherently state-based...
Everyone knows you can’t compare apples and oranges. Yet that’s exactly what prescription drug affordability boards do when they make decisions about value. Now, a new video from the Value of Care Coalition outlines how this one-size-fits-all approach ignores clinical...
Comparing two drugs is like comparing apples to oranges. But prescription drug affordability boards take this one-size-fits-all approach to decisions about...
Specialty doctors are concerned about the harmful impacts of prescription drug affordability boards, a white paper commissioned by the Value of Care Coalition recently found. The survey asked endocrinologists, rheumatologists and HIV specialists for their opinions on...
